Researchers concluded, “More than half of opioid users at baseline were able to [either] discontinue or decrease [their] opioid use after starting medical cannabis.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Authors determined that these reductions have led to approximately 21,000 fewer criminal interactions between police and young people in the years following nationwide legalization.
“A lot more research is needed to show that a cannabis breathalyzer can produce useful results,” the study’s lead author concluded.
Researchers concluded: “We suggest that CBD may be a more effective and safe choice for managing behavioral and psychological symptoms of dementia.”
Investigators concluded, “In this nationally representative sample, current marijuana use is inversely associated with steatosis.”
The study’s authors determined, “Most participants across all formulations experienced a clinically important improvement in their sleep quality.”
“Patients using medical cannabis reported an average 75 percent tic reduction compared with baseline,” investigators determined.
“Medical cannabis improves motor and nonmotor symptoms in patients with PD and may allow for reduction of concomitant opioid medication use,” authors concluded.